Version 5.4
Bos taurus Gene: BT.35117
Summary
InnateDB Gene IDBG-637747.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.35117
Gene Name leucine-rich glioma-inactivated protein 1 precursor
Synonyms
Species Bos taurus
Ensembl Gene ENSBTAG00000005106
Encoded Proteins
IDBP-689773
leucine-rich glioma-inactivated protein 1 precursor
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000108231:
This gene is rearranged as a result of translocations in glioblastoma cell lines. The protein contains a hydrophobic segment representing a putative transmembrane domain with the amino terminus located outside the cell. It also contains leucine-rich repeats with conserved cysteine-rich flanking sequences. This gene is predominantly expressed in neural tissues and its expression is reduced in low grade brain tumors and significantly reduced or absent in malignant gliomas. Mutations in this gene result in autosomal dominant lateral temporal epilepsy. [provided by RefSeq, Jul 2008]
Gene Information
Type Protein coding
Genomic Location Chromosome 26:15126483-15134920
Strand Forward strand
Band
Transcripts
ENSBTAT00000006728 ENSBTAP00000006728
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Predicted by orthology
Total 3 [view]
Orthologs
Species
Homo sapiens
Mus musculus
Gene ID
Gene Order
ENSG00000108231
View Gene Order
ENSMUSG00000067242
View Gene Order
Cross-References
SwissProt
TrEMBL G3X6H4
UniProt Splice Variant
Entrez Gene 617080
UniGene Bt.35117
RefSeq NM_001046591 XM_003585038
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02058842
GenPept
RNA Seq Atlas 100851579 617080

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca